We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
+9.26%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$2.21B
AUM Growth
+$110M
Cap. Flow
-$79.3M
Cap. Flow %
-3.59%
Top 10 Hldgs %
22.7%
Holding
3,121
New
66
Increased
341
Reduced
717
Closed
30

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$3.73M
2
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$3.01M
3
COP icon
ConocoPhillips
COP
+$2.6M
4
NOW icon
ServiceNow
NOW
+$1.95M
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$1.95M

Top Sells

Rank Stock Value
1
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$6.14M
2
MSFT icon
Microsoft
MSFT
+$4.3M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$3.96M
4
TER icon
Teradyne
TER
+$3.85M
5
ETSY icon
Etsy
ETSY
+$3.81M

Sector Composition

Rank Sector Weight
1 Technology 17.97%
2 Consumer Discretionary 10.47%
3 Healthcare 9.98%
4 Financials 9.67%
5 Industrials 9.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BLFS icon
2051
BioLife Solutions
BLFS
$1.72B
$34K ﹤0.01%
1,171
+582
+99% +$12.6K
BRSP
2052
BrightSpire Capital
BRSP
$629M
$34K ﹤0.01%
6,877
– –
CAL icon
2053
Caleres
CAL
$455M
$34K ﹤0.01%
3,593
– –
CIO
2054
DELISTED
City Office REIT
CIO
$34K ﹤0.01%
4,586
– –
CIVI
2055
DELISTED
Civitas Resources
CIVI
$34K ﹤0.01%
1,784
– –
DVAX
2056
DELISTED
Dynavax Technologies
DVAX
$34K ﹤0.01%
7,901
– –
FLGT icon
2057
Fulgent Genetics
FLGT
$515M
$34K ﹤0.01%
854
– –
FNDE icon
2058
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
$9.95B
$34K ﹤0.01%
1,468
– –
GPMT
2059
Granite Point Mortgage Trust
GPMT
$58.8M
$34K ﹤0.01%
4,738
– –
GSBC icon
2060
Great Southern Bancorp
GSBC
$877M
$34K ﹤0.01%
940
– –
HY icon
2061
Hyster-Yale Materials Handling
HY
$614M
$34K ﹤0.01%
907
– –
LILA icon
2062
Liberty Latin America Class A
LILA
$1.69B
$34K ﹤0.01%
6,100
-372
-6% -$2.27K
NPK icon
2063
National Presto Industries
NPK
$998M
$34K ﹤0.01%
420
– –
OCUL icon
2064
Ocular Therapeutix
OCUL
$2.22B
$34K ﹤0.01%
4,529
– –
PHAT icon
2065
Phathom Pharmaceuticals
PHAT
$743M
$34K ﹤0.01%
925
– –
TM icon
2066
Toyota
TM
$223B
$34K ﹤0.01%
258
+37
+17% +$4.81K
GTHX
2067
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$34K ﹤0.01%
2,920
– –
SP
2068
DELISTED
SP Plus Corporation
SP
$34K ﹤0.01%
1,895
– –
BCEL
2069
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$34K ﹤0.01%
2,420
+540
+29% +$8.05K
AMTI
2070
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$34K ﹤0.01%
+1,058
New +$26K
KBAL
2071
DELISTED
Kimball International
KBAL
$34K ﹤0.01%
3,203
– –
WTRE
2072
DELISTED
Watford Holdings Ltd. Common Shares
WTRE
$34K ﹤0.01%
1,476
-310
-17% -$5.67K
EIGI
2073
DELISTED
Endurance International Group Holdings, Inc.
EIGI
$34K ﹤0.01%
5,998
– –
ARLO icon
2074
Arlo Technologies
ARLO
$1.54B
$33K ﹤0.01%
6,268
– –
AVD icon
2075
American Vanguard Corp
AVD
$64M
$33K ﹤0.01%
2,506
– –
81 82
83
84 85

Similar funds

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $3.78B AUM 33.04% 1-Year Est. Return
SB
SIG Brokerage New York $3.79B AUM 44.46% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return

Ameritas Investment Partners's Q3 2020 Portfolio in Review

As of Q3 2020, Ameritas Investment Partners held 3,121 positions worth $2.21B, up 5.2% from $2.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Ameritas Investment Partners withdrew a net $79.3M in Q3 2020, closing 30 positions and reducing 717 holdings. Its most notable exit was Caesars Entertainment Corporation, an estimated $1.97M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Ameritas Investment Partners opened a new position in Jazz Pharmaceuticals worth $2.24M.

  • Ameritas Investment Partners's largest Q3 2020 buy was Jazz Pharmaceuticals: 15,701 shares worth $2.24M.
  • Ameritas Investment Partners added most to Invesco QQQ Trust in Q3 2020, an estimated $3.73M increase.
  • Ameritas Investment Partners's biggest Q3 2020 reduction was State Street SPDR S&P MIDCAP 400 ETF Trust, cutting an estimated $6.14M.
  • Ameritas Investment Partners fully exited Caesars Entertainment Corporation in Q3 2020, selling an estimated $1.97M.
  • Ameritas Investment Partners's ten largest holdings make up 23% of its $2.21B portfolio in Q3 2020.
  • Ameritas Investment Partners opened 66 new positions and closed 30 in Q3 2020.
  • Ameritas Investment Partners's portfolio value rose 5.2% quarter-over-quarter to $2.21B.

Based on Ameritas Investment Partners's 13F filing for Q3 2020, filed 13 Nov 2020.